Stock Markets November 17, 2026 04:36 AM

Stem Shares Collapse After Q3 Miss and Sharply Lowered 2026 Targets

Revenue shortfall and NYSE non-compliance notice overshadow record margins and positive adjusted EBITDA

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
STEM

Stem's stock plunged in pre-market trading after the energy storage software firm delivered third-quarter results that missed revenue forecasts and trimmed its full-year revenue and ARR targets. The company disclosed an NYSE non-compliance notice and included going-concern language in its latest filing, even as non-GAAP gross margin hit a record and adjusted EBITDA improved following a strategic pullback from lower-margin hardware resale and managed services.

Stem Shares Collapse After Q3 Miss and Sharply Lowered 2026 Targets
STEM
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Stem reported Q3 revenue of $36.7 million, missing analyst expectations by roughly 9% and declining 4% year-over-year.
  • Management narrowed full-year 2026 revenue guidance to $132 million–$142 million and reduced year-end ARR guidance to $50 million–$55 million.
  • Company disclosed an NYSE non-compliance notice and included going-concern language in its latest quarterly filing, though CEO Arun Narayanan said immediate delisting is not triggered and a remediation plan will be submitted.
  • Non-GAAP gross margin hit a record 58% and adjusted EBITDA rose to $7.1 million after exiting lower-margin hardware resale and managed services; the Athena platform was sold to Voltus for $10 million in cash.

Stem's shares tumbled sharply in pre-market trading, sliding 31.5% to $1.35 after the company reported third-quarter 2026 results that fell short of analyst expectations and prompted management to significantly lower its full-year outlook.

For Q3, Stem recorded revenue of $36.7 million, a figure that was about 9% below consensus and represented a 4% decline versus the year-ago quarter. In response to weaker near-term demand and other dynamics, management narrowed full-year 2026 revenue guidance to a range of $132 million to $142 million, down from the prior outlook of $140 million to $190 million. The company also trimmed its year-end annual recurring revenue (ARR) target to $50 million–$55 million, compared with the previous guidance of $65 million–$70 million.

Adding to investor unease, Stem disclosed that it has received a non-compliance notice from the NYSE concerning its market capitalization and stockholders' equity. The company's most recent quarterly filing contains going-concern language. During the earnings call, CEO Arun Narayanan said the notice does not trigger immediate delisting and that Stem intends to file a remediation plan with the exchange.


There were, however, operational developments that point to improved unit economics. Stem's non-GAAP gross margin reached a record 58%, and adjusted EBITDA rose to $7.1 million. Management attributed the profitability improvement in part to a deliberate withdrawal from lower-margin battery hardware resale and managed services, shifting emphasis toward its PowerTrack software offering.

As part of that strategic refocus, the company completed a $10 million cash sale of its Athena distributed battery optimization platform to Voltus. The divestiture was presented as a move to streamline Stem's business around higher-margin software activities.

The broader market offered little shelter for the stock. The report noted the S&P 500 was down about 0.5% in pre-market trading, while the Dow Jones Industrial Average and the Nasdaq Composite were each lower by around 0.6%, leaving growth-oriented names under pressure in early trading.


Taken together, the combination of a revenue miss, sharply reduced top-line guidance, a lower ARR target, and the NYSE non-compliance notice created a heavy negative sentiment that eclipsed improvements in margins and adjusted profitability. Those factors pushed the shares to multi-year lows in pre-market action.

The situation presents a mixed picture: the company has made measurable progress on gross margins and adjusted EBITDA through portfolio pruning and a shift toward software, yet the scale-down in revenue expectations and the regulatory overhang raise near-term financing and market access questions.

Risks

  • Regulatory and listing risk - The NYSE non-compliance notice and going-concern language present a risk to Stem's listing status and investor confidence, impacting availability of capital for the company and related activity in the energy storage sector.
  • Top-line uncertainty - Lowered full-year revenue and ARR targets indicate potential demand weakness and reduce visibility on growth, which affects expectations for software revenue recovery within energy storage and clean-tech markets.
  • Market sensitivity - The wider pullback in growth-oriented equities and weaker market breadth could amplify selling pressure on Stem and other small-cap renewable or software-focused names.

More from Stock Markets

Samsung and Apple Near Deal for Multi-Year DRAM Supply Nov 17, 2026 Intel Shares Slip After Nvidia Reduces Stake and Legal Filings Surface Nov 17, 2026 Red Cat Shares Dive After Q3 Miss and Withdrawal of 2026 Revenue Goal Nov 17, 2026 Reach Subsea Plunges After Weak Q3 Results, Cash Drop and Strategic Split Spur Selling Nov 17, 2026 Gedeon Richter to Buy Mayne Pharma for A$604 Million; Mayne Shares Rally Sharply Nov 16, 2026